Literature DB >> 29117854

Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.

Sung Hoon Nam1, Jong-Lyel Roh1, Gyungyup Gong2, Kyung-Ja Cho2, Seung-Ho Choi1, Soon Yuhl Nam1, Sang Yoon Kim1.   

Abstract

BACKGROUND: Lymph node (LN) yield and ratio are considered important predictors of post-treatment outcomes for several human cancers. This study examined the association between nodal factors, including the LN yield and ratio, with recurrence after thyroidectomy plus central compartment neck dissection (ND) for papillary thyroid carcinoma (PTC).
MATERIALS AND METHODS: This retrospective study involved 2384 consecutive patients who underwent a thyroidectomy plus central compartment ND combined with (n = 440) or without lateral compartment ND at the authors' tertiary referral center between 2006 and 2012. The number of harvested LNs, as well as other tumor and nodal findings, were carefully reviewed. Univariable and multivariable Cox proportional hazards regression models were conducted to predict recurrence and its association with clinicopathologic variables.
RESULTS: All nodal factors, including the positive number of LNs, ratio, and extranodal extension, were significantly associated with nodal and any-site recurrence after thyroidectomy, as well as the tumor size and multifocality (p < 0.01). The multivariable analysis showed that tumor size, multifocality, LN ratio, and extranodal extension were independent factors predictive of post-treatment recurrence (p < 0.05). The LN yield was higher in patients with nodal recurrence but did not significantly affect the nodal recurrence. Patients with a LN ratio >0.3 exhibited a 1.7-fold higher risk of post-treatment nodal recurrence than their counterparts (p < 0.01).
CONCLUSIONS: LN ratio is an independent determinant predictive of nodal and any-site recurrence following thyroidectomy for PTC.

Entities:  

Keywords:  lymph node ratio; lymph node yield; nodal metastasis; papillary thyroid carcinoma; recurrence

Mesh:

Year:  2017        PMID: 29117854     DOI: 10.1089/thy.2017.0334

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

1.  Male patients with papillary thyroid cancer have a higher risk of extranodal extension.

Authors:  Hu Hei; Bin Zhou; Wenbo Gong; Chen Zheng; Jianwu Qin
Journal:  Int J Clin Oncol       Date:  2022-01-08       Impact factor: 3.402

2.  Sex disparities in thyroid cancer: a SEER population study.

Authors:  Peng Li; Ying Ding; Mengyuan Liu; Wenlong Wang; Xinying Li
Journal:  Gland Surg       Date:  2021-12

3.  Mitoxantrone hydrochloride injection for tracing helps to decrease parathyroid gland resection and increase lymph node yield in thyroid cancer surgery: a randomized clinical trial.

Authors:  Shaobo Chen; Xianming Hou; Surong Hua; Ziwen Liu; Binglu Li; Xiaoyi Li; Lin Cong; Quan Liao; Jugao Fang; Lizhen Hou; Shanghua Jing; Zhen Zhao; Jianwu Qin; Songtao Zhang; Zhendong Li; Dongning Huang; Ning Zhang; Yongfu Zhao; Jun Liu; Shujun Wang; Ge Chen; Yupei Zhao
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 4.  Recurrence of papillary thyroid carcinoma from the residual pyramidal lobe: a case report and literature review.

Authors:  Mingjun Wang; Xiuhe Zou; Zhihui Li; Jingqiang Zhu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma.

Authors:  Hye In Kim; Jiyeon Hyeon; So Young Park; Hyeon Seon Ahn; Kyunga Kim; Ji Min Han; Ji Cheol Bae; Jung Hee Shin; Jee Soo Kim; Sun Wook Kim; Jae Hoon Chung; Tae Hyuk Kim; Young Lyun Oh
Journal:  Thyroid       Date:  2019-05-30       Impact factor: 6.568

6.  Preoperative Nodal US Features for Predicting Recurrence in N1b Papillary Thyroid Carcinoma.

Authors:  Na Lae Eun; Jeong-Ah Kim; Hye Mi Gweon; Ji Hyun Youk; Eun Ju Son
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

7.  A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.

Authors:  Zheyu Yang; Yu Heng; Qiwu Zhao; Zichao Cao; Lei Tao; Weihua Qiu; Wei Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

Review 8.  Papillary Thyroid Cancer Prognosis: An Evolving Field.

Authors:  Salvatore Ulisse; Enke Baldini; Augusto Lauro; Daniele Pironi; Domenico Tripodi; Eleonora Lori; Iulia Catalina Ferent; Maria Ida Amabile; Antonio Catania; Filippo Maria Di Matteo; Flavio Forte; Alberto Santoro; Piergaspare Palumbo; Vito D'Andrea; Salvatore Sorrenti
Journal:  Cancers (Basel)       Date:  2021-11-07       Impact factor: 6.639

Review 9.  Clinical outcomes of multifocal papillary thyroid cancer: A systematic review and meta-analysis.

Authors:  Likun Cui; Dongdong Feng; Chaofan Zhu; Qiuyu Li; Wenqing Li; Baoguo Liu
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.